Literature DB >> 9245939

Helicobacter pylori, ammonia and the brain.

S D Taylor-Robinson1, N Jackson, C Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9245939      PMCID： PMC1027211          DOI： 10.1136/gut.40.6.805

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  8 in total

1.  Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.

Authors:  J STAHL
Journal:  Ann Intern Med       Date:  1963-01       Impact factor: 25.391

Review 2.  The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy.

Authors:  J P Seery; S D Taylor-Robinson
Journal:  J Hepatol       Date:  1996-12       Impact factor: 25.083

Review 3.  Review article: pathogenesis and treatment of chronic hepatic encephalopathy.

Authors:  R Jalan; J P Seery; S D Taylor-Robinson
Journal:  Aliment Pharmacol Ther       Date:  1996-10       Impact factor: 8.171

4.  Hyperammonaemia and Helicobacter pylori.

Authors:  S Ito; H Miyaji; T Azuma; Y Li; Y Ito; T Kato; Y Kohli; M Kuriyama
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

5.  Hyperammonaemia in cirrhosis and Helicobacter pylori infection.

Authors:  J N Plevris; R Morgenstern; P C Hayes; I A Bouchier
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

6.  Hyperammonaemia and Helicobacter pylori.

Authors:  J C Quero; I J Hartmann; F de Rooij; J H Wilson; S W Schalm
Journal:  Lancet       Date:  1995-09-09       Impact factor: 79.321

7.  Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275.

Authors:  G P Gubbins; T E Moritz; L S Marsano; R Talwalkar; C J McClain; C L Mendenhall
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

Review 8.  Awakenings to the pathogenicity of urease and the requirement for continuous long term therapy.

Authors:  H H LeVeen; E G LeVeen; R F LeVeen
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529
  8 in total
  5 in total

1.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

3.  Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion.

Authors:  Michal A Olszewski; Mairi C Noverr; Gwo-Hsiao Chen; Galen B Toews; Gary M Cox; John R Perfect; Gary B Huffnagle
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

4.  Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.

Authors:  Edoardo Giannini; Alberto Fasoli; Federica Botta; Paola Romagnoli; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

5.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.